Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 63.21B | 64.25B | 60.60B | 57.53B | 52.83B | 45.41B |
Gross Profit | 17.57B | 17.81B | 16.25B | 14.42B | 14.47B | 13.30B |
EBITDA | 6.22B | 7.56B | 5.72B | 4.90B | 5.11B | 4.62B |
Net Income | 4.35B | 4.65B | 3.71B | 2.82B | 2.87B | 2.50B |
Balance Sheet | ||||||
Total Assets | 71.94B | 70.65B | 67.88B | 65.56B | 61.76B | 55.30B |
Cash, Cash Equivalents and Short-Term Investments | 36.61B | 35.85B | 33.07B | 31.58B | 29.10B | 22.62B |
Total Debt | 0.00 | 12.68M | 183.43M | 383.08M | 638.39M | 1.05B |
Total Liabilities | 24.74B | 22.16B | 22.61B | 22.17B | 20.28B | 16.22B |
Stockholders Equity | 47.20B | 48.49B | 45.27B | 43.39B | 41.47B | 39.07B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 4.52B | 3.93B | 3.46B | 7.06B | 373.47M |
Operating Cash Flow | 0.00 | 5.43B | 4.66B | 4.10B | 7.69B | 1.53B |
Investing Cash Flow | 0.00 | -12.91B | -759.78M | -638.14M | -712.14M | -1.12B |
Financing Cash Flow | 0.00 | -1.75B | -2.41B | -978.83M | -494.24M | -901.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥56.94B | 10.46 | 3.14% | -3.26% | 11.02% | ||
79 Outperform | ¥51.76B | 10.19 | 3.33% | 4.49% | 88.35% | ||
79 Outperform | ¥56.55B | 13.13 | 3.24% | 1.85% | -11.39% | ||
75 Outperform | ¥54.05B | 10.79 | 4.00% | 5.64% | -4.56% | ||
73 Outperform | ¥55.60B | 11.97 | 4.05% | 6.03% | 27.82% | ||
66 Neutral | ¥51.48B | 11.63 | 3.23% | 2.75% | -0.09% | ||
65 Neutral | $10.75B | 15.69 | 5.29% | 1.89% | 3.09% | -27.41% |